Citation Impact
Citing Papers
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
Rhizobium induces DNA damage in Caenorhabditis elegans intestinal cells
2019 StandoutNobel
Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2 : A Report by MSKCC and the KIRC TCGA Research Network
2013
Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy
2014
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
2005 StandoutNobel
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
2015 StandoutNobel
An overview of clinical decision support systems: benefits, risks, and strategies for success
2020 Standout
Serotonin: a review
2008
The molecular hallmarks of epigenetic control
2016 Standout
Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components
2016
A river model to map convergent cancer evolution and guide therapy in RCC
2015
Role of Imaging in the Era of Precision Medicine
2017
Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations between CT Imaging Features and Mutations
2013
Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects
2013
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Targeting HIF2 in Clear Cell Renal Cell Carcinoma
2016 StandoutNobel
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways
2014 StandoutNobel
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
2015 StandoutNobel
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
2017 Standout
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype
2015
Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney Cancer
2015 StandoutNobel
Driver mutations of cancer epigenomes
2014
Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer
2016
Histone Modifications and Cancer
2016
VHL, the story of a tumour suppressor gene
2014
Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma
2015
VHL and Kidney Cancer
2003 StandoutNobel
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
The PI3K Pathway in Human Disease
2017 Standout
Renal cell carcinoma
2017 Standout
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway
2017 StandoutNobel
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
An intact NEDD8 pathway is required for Cullin‐dependent ubiquitylation in mammalian cells
2002 StandoutNobel
Identifying molecular genetic features and oncogenic pathways of clear cell renal cell carcinoma through the anatomical (PADUA) scoring system
2016
Fundamentals of cancer metabolism
2016 Standout
Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL −/− clear cell renal carcinoma
2017 StandoutNobel
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
2002 StandoutNobel
DNA methylation in the central and efferent limbs of the chemoreflex requires carotid body neural activity
2017 StandoutNobel
Placebo-controlled double-blind clomipramine trial for the treatment of anxiety or fear in beagles during ground transport.
2006
The von Hippel-Lindau Tumor Suppressor Gene
2020
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
2016 StandoutScienceNobel
BAF180: Its Roles in DNA Repair and Consequences in Cancer
2017
The use of leukocyte profiles to measure stress in vertebrates: a review for ecologists
2008 Standout
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling
2014
Diverse Effects of Mutations in Exon II of the von Hippel-Lindau (VHL) Tumor Suppressor Gene on the Interaction of pVHL with the Cytosolic Chaperonin and pVHL-Dependent Ubiquitin Ligase Activity
2002 StandoutNobel
Works of James Wren being referenced
Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma
2012
Treatment of separation anxiety in dogs with clomipramine: results from a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial
2000